i-SENS, Inc.

Clinical trials sponsored by i-SENS, Inc., explained in plain language.

i-SENS, Inc. 099190 KOSDAQ

Medical device company specializing in blood glucose monitoring systems.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Trials to join now! 1

New blood sugar monitor put to the test in type 1 diabetes trial

Diagnosis Recruiting now

This study is testing how well a new continuous glucose monitor, called CareSens Air 3, measures blood sugar levels in adults with type 1 diabetes. Researchers will compare the monitor's readings to standard lab measurements. The goal is to see if the device is accurate and preci…

Sponsor: i-SENS, Inc. • Aim: Diagnosis

Last updated Jun 27, 2026 12:05 UTC

i-SENS, Inc.

New blood sugar monitor put to the test in type 1 diabetes trial